"Uncovering the Dark Side of Spotify: Fake Podcasts Peddling Addictive Drugs"
Read "Uncovering the Dark Side of Spotify: Fake Podcasts Peddling Addictive Drugs" on RadioNOVO
"Uncovering the Dark Side of Spotify: Fake Podcasts Peddling Addictive Drugs"
[!CDATA[The prevalence of fake podcasts promoting the sale of addictive drugs on Spotify has come to light after an investigation by Business Insider. These podcasts, often less than a minute long, advertise opioids like tramadol and oxycodone without a prescription, directing users to websites posing as legitimate online pharmacies. Despite Spotify's guidelines prohibiting content that promotes controlled substances, many of these podcasts were only removed after being flagged by users or BI. Some podcasts featured no audio, relying solely on episode descriptions or cover art to provide URLs or instructions on purchasing drugs. Business Insider identified over 25 types of opioids, benzodiazepines, and weight-loss medications being marketed, including Opana, a potent opioid removed from the US market in 2017 due to its high abuse potential. While some of these drugs are prescribed for medical conditions, others pose risks of dependence, abuse, and overdose. The online pharmacies promoted in these podcasts claim to have doctors who can assess a customer's condition but promise quick and discreet delivery of drugs without requiring a prescription. This violates federal law, which mandates that prescription medications be dispensed only with a valid prescription from a licensed healthcare professional. Unregulated drug sales pose significant public health risks, as the drugs sold may be counterfeit, contaminated, or expired. Although the websites linked in the podcasts lead users to payment pages, it remains unclear whether the drugs are actually delivered. Customer reviews for some of these sites indicate that they did not receive the drugs they paid for. The potential harm caused by these illicit drug sales underscores the importance of cracking down on such activities to protect public health and safety. If you have any information to share on this issue, you can contact the reporter via email at [email protected] or Signal at jyotimann.11. It is recommended to use a personal email address and a non-work device for secure communication.]]